|1.||Choi, Kyung-Chul: 9 articles (10/2015 - 06/2011)|
|2.||Soto, Ana M: 8 articles (09/2015 - 05/2002)|
|3.||Baskin, Laurence S: 8 articles (05/2015 - 03/2006)|
|4.||Heindel, Jerrold J: 7 articles (11/2015 - 12/2003)|
|5.||Hwang, Kyung-A: 7 articles (10/2015 - 06/2011)|
|6.||Sargis, Robert M: 7 articles (09/2015 - 07/2010)|
|7.||Sonnenschein, Carlos: 6 articles (09/2015 - 05/2002)|
|8.||Vrijheid, Martine: 5 articles (10/2015 - 07/2002)|
|9.||Prins, Gail S: 5 articles (10/2015 - 06/2006)|
|10.||Newbold, Retha R: 5 articles (12/2011 - 04/2007)|
|1.||Cardiovascular Diseases (Cardiovascular Disease)
|2.||Wounds and Injuries (Trauma)
01/01/2014 - "However, coadministration of GEN could partially alleviate DEHP-induced reproductive injuries via enhancement of testicular antioxidative enzymes activities, which indicates that GEN has protective effects on DEHP-induced male reproductive system damage after prepubertal exposure and GEN may have promising future in its curative antioxidative role for reproductive disorders caused by other environmental endocrine disruptors. "
04/01/2015 - "There is irrefutable evidence from human and animal studies that nutrient and environmental agent exposures (for example, endocrine disruptors) during pregnancy may affect fetal/newborn development resulting in offspring obesity and obesity-associated metabolic abnormalities (metabolic syndrome). "
02/01/2015 - "A few earlier studies have associated exposure to endocrine-disrupting chemicals (EDCs) with childhood obesity. "
09/01/2013 - "Recent studies suggest that endocrine disrupting chemicals (EDCs) may form a risk factor for obesity by altering energy metabolism through epigenetic gene regulation. "
08/15/2012 - "Epidemiology studies indicate that exposure to endocrine disruptors during developmental "window" contributes to adipogenesis and the development of obesity. "
08/01/2011 - "The study findings suggest that some endocrine disruptors may play a role for the development of the obesity epidemic, in addition to the more commonly perceived putative contributors."
12/01/2015 - "Numerous studies have focused on the association between endocrine-disrupting chemicals (EDCs) and hypospadias. "
01/01/2011 - "The study provides some but limited evidence that occupational exposure to possible endocrine disrupting chemicals during pregnancy increases the risk of hypospadias."
08/01/2004 - "Recent studies have implicated factors such as familial inheritance, low birth weight, assisted reproductive technology, advanced maternal age, paternal subfertility, and endocrine-disrupting chemicals in the pathogenesis of hypospadias. "
07/01/2002 - "A study to assess the association between the prevalence of hypospadias and maternal occupational exposure to potential endocrine-disrupting chemicals was carried out using data from the congenital anomaly register of the Office for National Statistics. "
07/01/2002 - "A job-exposure matrix for potential endocrine-disrupting chemicals developed for a study into the association between maternal occupational exposure and hypospadias."
07/01/2015 - "In conclusion, the carcinogenic effects of endocrine disruptors on female cancer types is plausible although additional studies are needed to clarify their mechanisms and entities. "
10/01/1999 - "The purpose of this study was to find out some clues for generating a working hypothesis that the contamination of drinking water with environmental chemicals especially of endocrine disrupting chemicals in big rivers may be related to the occurrence of cancers. "
10/01/2015 - "It is long recognized that environmental factors play a major role in cancer etiology, and emerging data suggest that endocrine-disrupting chemicals (EDCs) may contribute to an increased cancer risk. "
07/01/2015 - "Pollutants altering the endocrine system, known as endocrine disruptors (ED), may modify the risk of female cancers. "
07/01/2015 - "Endocrine disruptors and female cancer: Informing the patients (Review)."
|2.||Diethylhexyl Phthalate (DEHP)
|5.||Biological Markers (Surrogate Marker)
|9.||Aryl Hydrocarbon Receptors (Aryl Hydrocarbon Receptor)
|2.||Heterologous Transplantation (Xenotransplantation)
|5.||Drug Therapy (Chemotherapy)